Arvinas chief accounting officer David Loomis sells 10,300 in stock
PFE Stock | USD 25.65 0.52 2.07% |
About 57% of all Pfizer's shareholders are looking to take a long position. The analysis of overall sentiment of trading Pfizer Inc stock suggests that some investors are interested at this time. The current market sentiment, together with Pfizer's historical and current headlines, can help investors time the market. In addition, many technical investors use Pfizer Inc stock news signals to limit their universe of possible portfolio assets.
Pfizer |
Arvinas chief accounting officer David Loomis sells 10,300 in stock
Read at investing.com
Pfizer Inc Current Investor Sentiment
Panic Vs Confidence
57
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Pfizer's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Pfizer Inc.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
Pfizer Inc Historical Investor Sentiment
Investor biases related to Pfizer's public news can be used to forecast risks associated with an investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pfizer's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pfizer and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Pfizer news discussions. The higher the estimate score, the more favorable the investor's outlook on Pfizer.
Pfizer Fundamental Analysis
We analyze Pfizer's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Pfizer is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Pfizer Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pfizer stock to make a market-neutral strategy. Peer analysis of Pfizer could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics with similar companies.
Peers
Pfizer Related Equities
SLNO | Soleno Therapeutics | 5.77 | ||||
TIL | Instil Bio | 5.61 | ||||
CAPR | Capricor Therapeutics | 4.67 | ||||
BPTH | Bio Path | 2.50 | ||||
CTMX | CytomX Therapeutics | 2.30 | ||||
ASMB | Assembly Biosciences | 2.17 | ||||
ACHL | Achilles Therapeutics | 0.93 | ||||
CRNX | Crinetics Pharmaceuticals | 1.70 | ||||
MBRX | Moleculin Biotech | 3.53 |
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |